XERS
NASDAQ · Pharmaceuticals
Xeris Biopharma Holdings Inc
$8.20
+0.04 (+0.49%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+468.9% upside
Low Target
$35.62
Average Target
$46.65
High Target
$60.75
Current Price
$8.20
Current
$8.20
$8.20
Target
$46.65
$46.65
$35.62
$46.65 avg
$60.75
Scenario Analysis
Bear Case
$35.62
334.4%
Low target
Base Case
$46.65
+468.9%
Avg target
Bull Case
$60.75
+640.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$10.08
-18.7% from high
52-Week Low
$5.25
+56.2% from low
Target vs 52W High
$46.65
+362.8% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +13.7% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.3% |
| MRK | Buy | 36 | 72% | $159.27 | +5.5% |
| PFE | Hold | 36 | 39% | $33.90 | +21.4% |
| BMY | Hold | 35 | 43% | $174.50 | +180.3% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +188.0% |